Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Maravai LifeSciences Holdings Inc’s stock clocked out at $5.50, down -1.96% from its previous closing price of $5.61. In other words, the price has decreased by -$1.96 from its previous closing price. On the day, 1.78 million shares were traded. MRVI stock price reached its highest trading level at $6.0378 during the session, while it also had its lowest trading level at $5.485.
Ratios:
To gain a deeper understanding of MRVI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.94 and its Current Ratio is at 10.74. In the meantime, Its Debt-to-Equity ratio is 1.63 whereas as Long-Term Debt/Eq ratio is at 1.59.
On December 05, 2024, Goldman Downgraded its rating to Sell which previously was Neutral but kept the price unchanged to $4.25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when DeFord John A bought 17,500 shares for $5.75 per share. The transaction valued at 100,625 led to the insider holds 70,046 shares of the business.
HULL CARL bought 175,000 shares of MRVI for $987,000 on Nov 11 ’24. The insider now owns 175,000 shares after completing the transaction at $5.64 per share. On May 28 ’24, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 9,940,974 shares for $9.81 each. As a result, the insider received 97,570,660 and left with 20,150,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 1388903936 and an Enterprise Value of 1083312256. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.02 while its Price-to-Book (P/B) ratio in mrq is 2.26. Its current Enterprise Value per Revenue stands at 3.912 whereas that against EBITDA is 1045.668.
Stock Price History:
The Beta on a monthly basis for MRVI is -0.06, which has changed by -0.032758594 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.28. The 50-Day Moving Average of the stock is 2.68%, while the 200-Day Moving Average is calculated to be -28.21%.
Shares Statistics:
It appears that MRVI traded 2.02M shares on average per day over the past three months and 1911790 shares per day over the past ten days. A total of 141.59M shares are outstanding, with a floating share count of 117.85M. Insiders hold about 16.91% of the company’s shares, while institutions hold 89.67% stake in the company. Shares short for MRVI as of 1736899200 were 8918685 with a Short Ratio of 4.41, compared to 1734048000 on 8292875. Therefore, it implies a Short% of Shares Outstanding of 8918685 and a Short% of Float of 7.5.
